Forecast & Rating4 analysts currently cover NRX Therapeutics, of which 4 give a positive rating. The average price target is $38.25, about 989.7% upside from the current price of $3.51. Coverage is limited, so the data is for reference only. Data as of Aug 18, 2026; this does not constitute investment advice.
Aug 17, 2026Price forecast
$38.25989.74%
Forecast & RatingStrong buy
4analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateAug 16, 2026
Forecast met0.0%
Stock price$3.51
Avg. target$38.3
High target$49
Low target$10
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.